Evidence map›Paper›PMID 31470655›Full record

ReviewJournal of clinical medicine2019

Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets.

Julien Guiot, Ingrid Struman, Edouard Louis, Renaud Louis, Michel Malaise, Makon-Sébastien Njock

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. miR‑205: A dual regulator of angiogenesis in health and disease (Review).International journal of molecular medicine · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  14. Review
  15. Exosome-encapsulated lncRNA HOTAIRM1 contributes to PMScience China. Life sciences · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Julien GuiotDepartment of Respiratory Diseases, GIGA-I3 Research Group, University and CHU of Liège, 4000 Liège, Belgium. j.guiot@chuliege.be.ORCID 0000-0001-7800-1730
Ingrid StrumanFibropôle Research Group, University and CHU of Liège, 4000 Liège, Belgium.
Edouard LouisFibropôle Research Group, University and CHU of Liège, 4000 Liège, Belgium.
Renaud LouisDepartment of Respiratory Diseases, GIGA-I3 Research Group, University and CHU of Liège, 4000 Liège, Belgium.
Michel MalaiseFibropôle Research Group, University and CHU of Liège, 4000 Liège, Belgium.
Makon-Sébastien NjockDepartment of Respiratory Diseases, GIGA-I3 Research Group, University and CHU of Liège, 4000 Liège, Belgium. ms.njock@chuliege.be.ORCID 0000-0001-8137-1978
University of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence suggests the potential role of extracellular vesicles (EVs) in many lung diseases. According to their subcellular origin, secretion mechanism, and size, EVs are currently classified into three subpopulations: exosomes, microvesicles, and apoptotic bodies. Exosomes are released in most biofluids, including airway fluids, and play a key role in intercellular communication via the delivery of their cargo (e.g., microRNAs (miRNAs)) to target cell. In a physiological context, lung exosomes present protective effects against stress signals which allow them to participate in the maintenance of lung homeostasis. The presence of air pollution alters the composition of lung exosomes (dysregulation of exosomal miRNAs) and their homeostatic property. Indeed, besides their potential as diagnostic biomarkers for lung diseases, lung exosomes are functional units capable of dysregulating numerous pathophysiological processes (including inflammation or fibrosis), resulting in the promotion of lung disease progression. Here, we review recent studies on the known and potential role of lung exosomes/exosomal miRNAs, in the maintaining of lung homeostasis on one hand, and in promoting lung disease progression on the other. We will also discuss using exosomes as prognostic/diagnostic biomarkers as well as therapeutic tools for lung diseases.

Indexed as

acute lung injury/acute respiratory distress syndromeasthmachronic obstructive pulmonary diseasediagnostic biomarkersexosomesidiopathic pulmonary fibrosislung diseasesmicroRNAstherapeutics

Identifiers

PMID31470655
PMCPMC6781233
OpenAlexW2971017846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.